BRIEF RESEARCH REPORT
Published on 12 May 2022
Wnt/β-Catenin Inhibition by CWP232291 as a Novel Therapeutic Strategy in Ovarian Cancer
doi 10.3389/fonc.2022.852260
- 4,220 views
- 9 citations
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Research Topics
- Women in Cancer Molecular Targets and Therapeutics: 2021
Women in Cancer Molecular Targets and Therapeutics: 2021
6,345
Total Downloads
25k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
MINI REVIEW
Published on 04 Apr 2022
Bacteria-Mediated Oncogenesis and the Underlying Molecular Intricacies: What We Know So Far
doi 10.3389/fonc.2022.836004
- 2,785 views
- 5 citations
ORIGINAL RESEARCH
Published on 21 Feb 2022
Actin Modulation Regulates the Alpha-1-Syntrophin/p66Shc Mediated Redox Signaling Contributing to the RhoA GTPase Protein Activation in Breast Cancer Cells
doi 10.3389/fonc.2022.841303
- 1,644 views
- 2 citations
CORRECTION
Published on 20 Dec 2021
Corrigendum: Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway
doi 10.3389/fonc.2021.822865
- 985 views
- 6 citations
REVIEW
Published on 05 Nov 2021
Emerging Functions and Clinical Applications of Exosomal ncRNAs in Ovarian Cancer
doi 10.3389/fonc.2021.765458
- 2,758 views
- 26 citations
REVIEW
Published on 06 Oct 2021
Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway
doi 10.3389/fonc.2021.741326
- 10,109 views
- 33 citations
Published in
Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
Participating Journals
Frontiers in Pharmacology
Cancer Molecular Targets and TherapeuticsOffline
- 4.4 impact factor
- 7.8 citescore
Impact
- 25kTopic views
- 18kArticle views
- 6,345Article downloads